Significance: This study suggests, for the first time, that MiRNA-96, by decreasing the expression of its target gene, it may: (1) decrease the expression of gluconeogenesis genes, such as PEPCK and G6Pase; (2) reduce hepatic glucose production; (3) improve insulin sensitivity; and (4) mimick the effects of exercise. Thus, pharmacological formulations encompassing “MiRNA-96 activators” may be used to inhibit insulin resistance and treat T2DM.
Undisclosed information: How MiRNA-96 mimicks the effects of exercise and promotes insulin sensitivity
Idea Proposed/Formulated by: Dr L Boominathan Ph.D.
Web: http://genomediscovery.org
Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/
To cite: Boominathan, MiRNA-based Exercise-Mimicking pill may inhibit Insulin resistance: MiRNA-96 decreases gluconeogenesis genes, such as PEPCK and G6Pase, reduces hepatic glucose production, and improves insulin sensivitity via down regulation of its target gene, 24/April/2015, 13.00 , Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org